The study published in the peer-reviewed Research Journal of Life Sciences May 2013 issue reported that a single dose of Sensoril provided a 12.85% increase in resistance to pain from a physical stress three hours after consumption. The results were highly significant (p≤0.001) and show in a clinical model how quickly Sensoril’s adaptogenic benefits can be experienced. The study was conducted by researchers at the Department of Clinical Pharmacology and Therapeutics at the NIZAMS Institute of Medical Sciences in Hyderabad, India.
In addition to the news of this most recent publication, Natreon and NutraGenesis have revealed that Sensoril’s specifications have been recently modified. According to the companies, the standardization level for these bioactives in Sensoril was recently increased by 25% from a minimum of 8% to a minimum of 10% glycowithanolides. The withaferin A standardization level was also modified from a maximum of 2% to 0.5%.
For further information: www.nutragenesis.com